An Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin Level

Bauer, Daniel E., Kamran, Sophia C., Lessard, Samuel, Xu, Jian, Fujiwara, Yuko, Lin, Carrie, Shao, Zhen, Canver, Matthew C., Smith, Elenoe C., Pinello, Luca, Sabo, Peter J., Vierstra, Jeff, Voit, Richard A., Yuan, Guo-Cheng, Porteus, Matthew H., Stamatoyannopoulos, John A., Lettre, Guillaume, Orkin, Stuart H.·2013·Science
DOI 10.1126/science.1242088

Cited by (656)

Items 101–200 of 656

  1. The Promise and the Hope of Gene Therapy
    Eleni Papanikolaou, Andreas Bosio · 2021 · Frontiers in Genome Editing
  2. KLF1-null neonates display hydrops fetalis and a deranged erythroid transcriptome
    Graham William Magor, Michael R. Tallack, Kevin Robert Gillinder, Charles C. Bell, Naomi McCallum, Bronwyn Williams, Andrew Charles Perkins · 2015 · Blood
  3. Laying a solid foundation for Manhattan – ‘setting the functional basis for the post-GWAS era’
    Xiaoyang Zhang, Swneke Donovan Bailey, Mathieu Lupien · 2014 · Trends in Genetics
  4. CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variants
    Sándor Spisák, Kate Lawrenson, Yanfang Fu, István Csabai, Rebecca T. Cottman, Ji-Heui Seo, Christopher A. Haiman, Ying Han, Romina Lenci, Qiyuan Li et al. · 2015 · Nature Medicine
  5. Decoding the genetic and epigenetic basis of asthma
    Bernard Stikker, Rudi W. Hendriks, Ralph Stadhouders · 2023 · Allergy
  6. Association of Variants at BCL11A and HBS1L-MYB with Hemoglobin F and Hospitalization Rates among Sickle Cell Patients in Cameroon
    Ambroise Wonkam, Valentina Josiane Ngo Bitoungui, Anna Alvera Vorster, Raj Ramesar, Richard Cooper, Bamidele O. Tayo, Guillaume Lettre, Jeanne Yonkeu Ngogang · 2014 · PLoS ONE
  7. Thalassemia 2016: Modern medicine battles an ancient disease
    Deborah G. Rund · 2015 · American Journal of Hematology
  8. Genome-wide Association Study of Platelet Count Identifies Ancestry-Specific Loci in Hispanic/Latino Americans
    Ursula M. Schick, Deepti Jain, Chani J. Hodonsky, Jean Morrison, James P. Davis, Lisa Brown, Tamar Sofer, Matthew P. Conomos, Claudia Schurmann, Caitlin McHugh et al. · 2016 · The American Journal of Human Genetics
  9. Genome-scale neurogenetics: methodology and meaning
    Steven A. McCarroll, Guoping Feng, Steven E. Hyman · 2014 · Nature Neuroscience
  10. Controlled Cycling and Quiescence Enables Efficient HDR in Engraftment-Enriched Adult Hematopoietic Stem and Progenitor Cells
    Jiyung J. Shin, Markus Schröder, Francisco Caiado, Stacia K. Wyman, Nicolas Bray, Matteo Bordi, Mark A. DeWitt, Jonathan T. Vu, Won‐Tae Kim, Dirk F. Hockemeyer et al. · 2020 · Cell Reports
  11. Therapeutic adenine base editing of human hematopoietic stem cells
    Jiaoyang Liao, Shuanghong Chen, Shenlin Hsiao, Yanhong Jiang, Yang Yang, Yuanjin Zhang, Xin Wang, Yongrong Lai, Daniel E. Bauer, Yuxuan Wu · 2023 · Nature Communications
  12. The LDB1 Complex Co-opts CTCF for Erythroid Lineage-Specific Long-Range Enhancer Interactions
    Jongjoo Lee, Ivan V. Krivega, Ryan Dale, Ann Dean · 2017 · Cell Reports
  13. Gene therapy of hemoglobinopathies: progress and future challenges
    Ikawa, Yasuhiro, Miccio, Annarita, Magrin, Elisa, Kwiatkowski, Janet L, Rivella, Stefano, Cavazzana, Marina · 2019 · Human Molecular Genetics
  14. Cell and Gene Therapy for the Beta-Thalassemias: Advances and Prospects
    Mansilla-Soto, Jorge, Riviere, Isabelle, Boulad, Farid, Sadelain, Michel · 2016 · Human Gene Therapy
  15. Fetal haemoglobin induction in sickle cell disease
    Alireza Paikari, Vivien Sheehan · 2017 · British Journal of Haematology
  16. Mining the Unknown: Assigning Function to Noncoding Single Nucleotide Polymorphisms
    Sierra S. Nishizaki, Alan P. Boyle · 2016 · Trends in Genetics
  17. Determinants of severity in sickle cell disease
    David C. Rees, Valentine A.M. Brousse, John N. Brewin · 2022 · Blood Reviews
  18. Current challenges in understanding the role of enhancers in disease
    Judith B. Zaugg, Pelin Sahlén, Robin Andersson, Meritxell Alberich-Jordà, Wouter L. de Laat, Bart Deplancke, Jorge P. Ferrer, Susanne Mandrup, Gioacchino Natoli, Dariusz Plewczyński et al. · 2022 · Nature Structural & Molecular Biology
  19. In vitro culture of stress erythroid progenitors identifies distinct progenitor populations and analogous human progenitors
    Jie Xiang, Dai-Chen Wu, Yuanting Chen, Robert F. Paulson · 2015 · Blood
  20. The European Hematology Association Roadmap for European Hematology Research: a consensus document
    Engert, A., Balduini, C., Brand, A., Coiffier, B., Cordonnier, C., Dohner, H., de Wit, T. D., Eichinger, S., Fibbe, W., Green, T. et al. · 2016 · Haematologica
  21. Molecular Basis and Genetic Modifiers of Thalassemia
    Nicolò Tesio, Daniel E. Bauer · 2023 · Hematology/Oncology Clinics of North America
  22. Histone acetylation dynamics modulates chromatin conformation and allele-specific interactions at oncogenic loci
    Sungalee, Stephanie, Liu, Yuanlong, Lambuta, Ruxandra A., Katanayeva, Natalya, Donaldson Collier, Maria, Tavernari, Daniele, Roulland, Sandrine, Ciriello, Giovanni, Oricchio, Elisa · 2021 · Nature Genetics
  23. The HRI-regulated transcription factor ATF4 activates BCL11A transcription to silence fetal hemoglobin expression
    Peng Huang, Scott A. Peslak, Xianjiang Lan, Eugene Khandros, Jennifer A. Yano, Malini Sharma, Cheryl A. Keller, Belinda M. Giardine, Kunhua Qin, Osheiza Y. Abdulmalik et al. · 2020 · Blood
  24. Interpreting non-coding disease-associated human variants using single-cell epigenomics
    Kyle J. Gaulton, Sebastian Preißl, Bing Ren · 2023 · Nature Reviews Genetics
  25. Ctip1 Regulates the Balance between Specification of Distinct Projection Neuron Subtypes in Deep Cortical Layers
    Mollie B. Woodworth, Luciano Custo Greig, Kevin X. Liu, Gregory C. Ippolito, Haley O. Tucker, Jeffrey D. Macklis · 2016 · Cell Reports
  26. The mTORC1/4E-BP pathway coordinates hemoglobin production with L -leucine availability
    Jacky Chung, Daniel E. Bauer, Alireza Ghamari, Christopher P. Nizzi, Kathryn M. Deck, Paul D. Kingsley, Yvette Y. Yien, Nicholas C. Huston, Caiyong Chen, Iman J. Schultz et al. · 2015 · Science Signaling
  27. An erythroid-specific ATP2B4 enhancer mediates red blood cell hydration and malaria susceptibility
    Samuel Lessard, Emily Stern Gatof, Mélissa Beaudoin, Patrick G. Schupp, Falak Sher, Adnan Ali, Sukhpal Prehar, Ryo Kurita, Yukio Nakamura, Esther Baena et al. · 2017 · Journal of Clinical Investigation
  28. De novo microdeletion of BCL11A is associated with severe speech sound disorder
    Beate Peter, Mark M. Matsushita, Kaori Oda, Wendy H. Raskind · 2014 · American Journal of Medical Genetics Part A
  29. A natural regulatory mutation in the proximal promoter elevates fetal globin expression by creating a de novo GATA1 site
    Gabriella E. Martyn, Beeke Wienert, Ryo Kurita, Yukio Nakamura, Kate G R Quinlan, Merlin Crossley · 2019 · Blood
  30. Functional validation of mouse tyrosinase non-coding regulatory DNA elements by CRISPR–Cas9-mediated mutagenesis
    Davide Seruggia, Almudena Fernández, Marta Cantero, Paweł Pelczar, Lluı́s Montoliu · 2015 · Nucleic Acids Research
  31. A Unique Epigenomic Landscape Defines Human Erythropoiesis
    Vincent Schulz, Hongxia Yan, Kimberly Lezon-Geyda, Xiuli An, John Hale, Christopher D. Hillyer, Narla Mohandas, Patrick G. Gallagher · 2019 · Cell Reports
  32. Genome-wide association analyses based on whole-genome sequencing in Sardinia provide insights into regulation of hemoglobin levels
    Fabrice Danjou, Magdalena Żołędziewska, Carlo Sidore, Maristella Steri, Fabio Busonero, Andrea Maschio, Antonella Mulas, Lucia Perseu, Susanna Barella, Eleonora Porcu et al. · 2015 · Nature Genetics
  33. A Rapid Molecular Approach for Chromosomal Phasing
    John F. Regan, Nolan Kamitaki, Tina C. Legler, Samantha Cooper, Niels Klitgord, George A. Karlin-Neumann, Tsz Wai Catherine Wong, Shawn P. Hodges, Ryan T. Koehler, Svilen Tzonev et al. · 2015 · PLoS ONE
  34. Nucleotide Pool Depletion Induces G-Quadruplex-Dependent Perturbation of Gene Expression
    Charikleia Papadopoulou, Guillaume Guilbaud, Davide Schiavone, Julian E. Sale · 2015 · Cell Reports
  35. Enhancers: bridging the gap between gene control and human disease
    Jaret M. Karnuta, Peter C. Scacheri · 2018 · Human Molecular Genetics
  36. PRDM16-dependent antigen-presenting cells induce tolerance to gut antigens
    Liuhui Fu, Rabi Upadhyay, Maria V. Pokrovskii, Francis M. Chen, Gabriela Romero‐Meza, Adam Griesemer, Dan R. Littman · 2025 · Nature
  37. 2p15-p16.1 microdeletions encompassing and proximal to BCL11A are associated with elevated HbF in addition to neurologic impairment
    Alister P. W. Funnell, Paolo Prontera, Valentina Ottaviani, Maria Piccione, Antonino Giambona, Aurelio Maggio, Fiorella Ciaffoni, Sandra Stehling-Sun, Manuela Marra, Francesca Masiello et al. · 2015 · Blood
  38. Functional interpretation of non‐coding sequence variation: Concepts and challenges
    Dirk S. Paul, Nicole Soranzo, Stephan Beck · 2013 · BioEssays
  39. Towards a new era in medicine: therapeutic genome editing
    Porteus, Matthew H. · 2015 · Genome Biology
  40. Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease
    Mohammad Ali Khosravi, Maryam Abbasalipour, Jean‐Paul Concordet, Johannes vom Berg, Sirous Zeinali, Arash Arashkia, Kayhan Azadmanesh, Thorsten Buch, Morteza Karimipoor · 2019 · European Journal of Pharmacology
  41. Editing GWAS: experimental approaches to dissect and exploit disease-associated genetic variation
    Shuquan Rao, Yao Yao, Daniel E. Bauer · 2021 · Genome Medicine
  42. Ctip1 Controls Acquisition of Sensory Area Identity and Establishment of Sensory Input Fields in the Developing Neocortex
    Luciano Custo Greig, Mollie B. Woodworth, Chloé Greppi, Jeffrey D. Macklis · 2016 · Neuron
  43. Common variation in atrial fibrillation: navigating the path from genetic association to mechanism
    Nathan R. Tucker, Sebastian Clauß, Patrick T. Ellinor · 2016 · Cardiovascular Research
  44. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
    Roland Meisel · 2021 · New England Journal of Medicine
  45. Sensitive detection of chromatin-altering polymorphisms reveals autoimmune disease mechanisms
    del Rosario, Ricardo Cruz-Herrera, Poschmann, Jeremie, Rouam, Sigrid Laure, Png, Eileen, Khor, Chiea Chuen, Hibberd, Martin Lloyd, Prabhakar, Shyam · 2015 · Nature Methods
  46. The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translation
    Dever, Daniel P., Porteus, Matthew H. · 2017 · Current Opinion in Hematology
  47. BCL11A enhancer–edited hematopoietic stem cells persist in rhesus monkeys without toxicity
    Selami Demirci, Jing Zeng, Yuxuan Wu, Naoya Uchida, Anne H. Shen, Danilo Pellin, Jackson Gamer, Morgan Yapundich, Claire M. Drysdale, Jasmine Bonanno et al. · 2020 · Journal of Clinical Investigation
  48. CRISPR/Cas9 for Sickle Cell Disease: Applications, Future Possibilities, and Challenges
    Demirci, Selami, Leonard, Alexis, Haro-Mora, Juan J., Uchida, Naoya, Tisdale, John F. · 2019 · Advances in Experimental Medicine and Biology
  49. Fetal Globin Gene Repressors as Drug Targets for Molecular Therapies To Treat the β-Globinopathies
    Mikiko Suzuki, Masayuki P. Yamamoto, James Douglas Engel · 2014 · Molecular and Cellular Biology
  50. Applying CRISPR–Cas9 tools to identify and characterize transcriptional enhancers
    Rui Lopes, Gözde Korkmaz, Reuven Agami · 2016 · Nature Reviews Molecular Cell Biology
  51. A Chromatin Basis for Cell Lineage and Disease Risk in the Human Pancreas
    H. Efsun Arda, Jennifer Tsai, Yenny Rosli, Paul G. Giresi, Rita Bottino, William James Greenleaf, Howard Y. Chang, Seung K. Kim · 2018 · Cell Systems
  52. Regulation of the fetal hemoglobin silencing factor BCL11A
    Anindita Basak, Vijay G. Sankaran · 2016 · Annals of the New York Academy of Sciences
  53. Common α-globin variants modify hematologic and other clinical phenotypes in sickle cell trait and disease
    Laura M. Raffield, Jacob C. Ulirsch, Rakhi P P. Naik, Samuel Lessard, Robert E. Handsaker, Deepti Jain, Hyun Min Kang, Nathan Pankratz, Paul Livermore Auer, Erik L. Bao et al. · 2018 · PLoS Genetics
  54. New Insights Into Pathophysiology of β-Thalassemia
    María Sánchez‐Villalobos, Miguel Blanquer, Jose Maria Moraleda, Eduardo José Salido, Ana B. Pérez‐Oliva · 2022 · Frontiers in Medicine
  55. Customizing the genome as therapy for the β-hemoglobinopathies.
    Canver, Matthew C., Orkin, Stuart H. · 2016 · Blood
  56. Redesign of extensive protein–DNA interfaces of meganucleases using iterative cycles of in vitro compartmentalization
    Ryo Takeuchi, Michael Y. Choi, Barry L. Stoddard · 2014 · Proceedings of the National Academy of Sciences
  57. Enhancing gene editing specificity by attenuating DNA cleavage kinetics
    Jeffrey C. Miller, Deepak P. Patil, Danny F. Xia, Charles B. Paine, Friedrich Fauser, Hunter W. Richards, David A. Shivak, Yuri R. Bendaña, Sarah J. Hinkley, Nicholas A. Scarlott et al. · 2019 · Nature Biotechnology
  58. Genetic and Epigenetic Fine Mapping of Complex Trait Associated Loci in the Human Liver
    Minal Çalışkan, Elisabetta Manduchi, H. Shanker Rao, Julian A. Segert, Márcia Holsbach Beltrame, Marco Trizzino, YoSon Park, Samuel W. Baker, Alessandra Chesi, Matthew E. Johnson et al. · 2019 · The American Journal of Human Genetics
  59. Single-nucleotide-level mapping of DNA regulatory elements that control fetal hemoglobin expression
    Li Cheng, Yichao Li, Qian Qi, Peng Xu, Ruopeng Feng, Lance E. Palmer, Jingjing Chen, Ruiqiong Wu, Tiffany Yee, Jingjing Zhang et al. · 2021 · Nature Genetics
  60. Chromatin Conformation in Development and Disease
    Ilias Boltsis, Frank G. Grosveld, Guillaume Giraud, Petros Kolovos · 2021 · Frontiers in Cell and Developmental Biology
  61. Erythro-megakaryocytic transcription factors associated with hereditary anemia
    John D. Crispino, Mitchell J. Weiss · 2014 · Blood
  62. Progress and challenges towards CRISPR/Cas clinical translation
    Daniel Rosenblum, Anna Gutkin, Niels Dammes, Dan Peer · 2020 · Advanced Drug Delivery Reviews
  63. Precision medicine, genomics and drug discovery: Table 1.
    Lon R. Cardon, Tim Harris · 2016 · Human Molecular Genetics
  64. APOL1 , α-thalassemia, and BCL11A variants as a genetic risk profile for progression of chronic kidney disease in sickle cell anemia
    Santosh L. Saraf, Binal N. Shah, Xu Zhang, Jin Han, Bamidele O. Tayo, Taimur A. Abbasi, Adam Ostrower, Elizabeth Guzman, Robert E. Molokie, Michel Gowhari et al. · 2016 · Haematologica
  65. CRISPR-Based Tools in Immunity
    Dimitre R. Simeonov, Alexander Marson · 2019 · Annual Review of Immunology
  66. Hydroxyurea down‐regulates BCL11A, KLF ‐ 1 and MYB through miRNA‐mediated actions to induce γ‐globin expression: implications for new therapeutic approaches of sickle cell disease
    Gift Dineo Pule, Shaheen Mowla, Nicolás Novitzky, Ambroise Wonkam · 2016 · Clinical and Translational Medicine
  67. Genetic Basis and Genetic Modifiers of β-Thalassemia and Sickle Cell Disease
    Swee Lay Thein · 2017 · Advances in experimental medicine and biology
  68. Thalassemias: from gene to therapy
    Giovanna De Simone, Alberto Quattrocchi, Benedetta Mancini, Alessandra di Masi, Clara Nervi, Paolo Ascenzi · 2021 · Molecular Aspects of Medicine
  69. The prevalence, genetic complexity and population-specific founder effects of human autosomal recessive disorders
    Qingyang Xiao, Volker Martin Lauschke · 2021 · npj Genomic Medicine
  70. Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease
    Paula Germino-Watnick, Malikiya Hinds, Anh Le, Rebecca Chu, Xiong Liu, Naoya Uchida · 2022 · Cells
  71. Genetic modifiers of fetal haemoglobin in sickle cell disease
    Menzel, Stephan, Thein, Swee Lay · 2019 · Molecular Diagnosis & Therapy
  72. Base editing of the HBG promoter induces potent fetal hemoglobin expression with no detectable off-target mutations in human HSCs
    Wenyan Han, Hou-Yuan Qiu, Shangwu Sun, Zhi-Can Fu, Guoquan Wang, Xiaowen Qian, Lijie Wang, Xiaowen Zhai, Wei Ping Jia, Yichuan Wang et al. · 2023 · Cell stem cell
  73. Enhancer–promoter specificity in gene transcription: molecular mechanisms and disease associations
    Meyer J. Friedman, Tobias Wagner, Haram Lee, Michael G. Rosenfeld, Soohwan Oh · 2024 · Experimental & Molecular Medicine
  74. Genetics and Genomics Approaches for Diagnosis and Research Into Hereditary Anemias
    Roberta Russo, Roberta Marra, Barbara Eleni Rosato, Achille Iolascon, Immacolata Andolfo · 2020 · Frontiers in Physiology
  75. Gene therapy for hemoglobinopathies: progress and challenges
    Alisa Dong, Stefano Rivella, Laura Breda · 2013 · Translational research
  76. Determining causality and consequence of expression quantitative trait loci
    Alexis J. Battle, Stephen B. Montgomery · 2014 · Human Genetics
  77. Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances
    Lantip Rujito, Muhammad Basalamah, Wahyu Siswandari, Joko Setyono, Gondo Wulandari, Sri Mulatsih, Abdul Salam M. Sofro, Ahmad Hamim Sadewa, Sutaryo Sutaryo · 2016 · Hematology/Oncology and Stem Cell Therapy
  78. TALEN-Mediated Gene Editing of HBG in Human Hematopoietic Stem Cells Leads to Therapeutic Fetal Hemoglobin Induction
    Christopher T. Lux, Sowmya Pattabhi, Mason P. Berger, Cynthia Nourigat, David A. Flowers, Olivier Nègre, Olivier Humbert, Julia Yang, Calvin Lee, Kyle Jacoby et al. · 2018 · Molecular Therapy — Methods & Clinical Development
  79. Beta Thalassemia
    Eugene Khandros, Janet L. Kwiatkowski · 2019 · Hematology/Oncology Clinics of North America
  80. Deregulated Regulators: Disease-Causing cis Variants in Transcription Factor Genes
    Robin van der Lee, Solenne Correard, Wyeth W. Wasserman · 2020 · Trends in Genetics
  81. Fetal hemoglobin in sickle cell anemia: The Arab‐Indian haplotype and new therapeutic agents
    Alawi H. Habara, Elmutaz Shaikho Elhaj Mohammed, Martin H. Steinberg · 2017 · American Journal of Hematology
  82. MIR-144-mediated NRF2 gene silencing inhibits fetal hemoglobin expression in sickle cell disease
    Yaqin Li, Xingguo Zhu, Christina Marie Ward, Athena Starlard‐Davenport, Mayuko Takezaki, Amber Berry, Alexander Ward, Caroline Wilder, Cindy E. Neunert, Abdullah Kutlar et al. · 2018 · Experimental Hematology
  83. CRISPR-SURF: discovering regulatory elements by deconvolution of CRISPR tiling screen data
    Jonathan Y. Hsu, Charles P. Fulco, Mitchel A. Cole, Matthew C. Canver, Danilo Pellin, Falak Sher, Rick Farouni, Kendell Clement, Jimmy A. Guo, Luca Biasco et al. · 2018 · Nature Methods
  84. Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation
    Samuele Ferrari, Valentina Vavassori, Daniele Canarutto, Aurélien Jacob, Maria Carmina Castiello, Attya Omer, Pietro Genovese · 2021 · Frontiers in Genome Editing
  85. CRISPR-Cas9 to induce fetal hemoglobin for the treatment of sickle cell disease
    Selami Demirci, Alexis Kristine Leonard, Khaled Essawi, John F. Tisdale · 2021 · Molecular Therapy — Methods & Clinical Development
  86. Demystifying non-coding GWAS variants: an overview of computational tools and methods
    Marijn Schipper, Daniëlle Posthuma · 2022 · Human Molecular Genetics
  87. A Cell-Permeant Nanobody-Based Degrader That Induces Fetal Hemoglobin
    Fangfang Shen, Ge Zheng, Mekedlawit T. Setegne, Karin Tenglin, Manizheh Izadi, Henry T.H. Xie, Liting Zhai, Stuart H. Orkin, Laura M. K. Dassama · 2022 · ACS Central Science
  88. Altered Chromatin Occupancy of Master Regulators Underlies Evolutionary Divergence in the Transcriptional Landscape of Erythroid Differentiation
    Jacob C. Ulirsch, Jessica N. Lacy, Xiuli An, Narla Mohandas, Tarjei Sigurd Mikkelsen, Vijay G. Sankaran · 2014 · PLoS Genetics
  89. Strict in vivo specificity of the Bcl11a erythroid enhancer
    Elenoe C. Smith, Sidinh Luc, Donyell M. Croney, Mollie B. Woodworth, Luciano Custo Greig, Yuko Fujiwara, Minh Nguyen, Falak Sher, Jeffrey D. Macklis, Daniel E. Bauer et al. · 2016 · Blood
  90. Fetal hemoglobin regulation in β-thalassemia: heterogeneity, modifiers and therapeutic approaches
    Orapan Sripichai, Suthat Fucharoen · 2016 · Expert Review of Hematology
  91. Genome editing in large animal models
    Lucy H. Maynard, Olivier Humbert, Christopher W. Peterson, Hans‐Peter Kiem · 2021 · Molecular Therapy
  92. 2015 Clinical trials update in sickle cell anemia
    Natasha M. Archer, F. Galactéros, Carlo Brugnara · 2015 · American Journal of Hematology
  93. Predicting enhancer activity and variant impact using gkm‐SVM
    M Beer · 2017 · Human Mutation
  94. Whole-genome noncoding sequence analysis in T-cell acute lymphoblastic leukemia identifies oncogene enhancer mutations
    Shaoyan Hu, Maoxiang Qian, Hui Zhang, Yu Amanda Guo, Jin Yang, Xujie Zhao, Hailong He, Jun Lu, Jian Pan, Meimei Chang et al. · 2017 · Blood
  95. Erythropoietin signaling regulates heme biosynthesis
    Jacky Chung, Johannes G. Wittig, Alireza Ghamari, Manami Maeda, Tamara A. Dailey, Hector A. Bergonia, Martin D. Kafina, Emma E. Coughlin, Catherine E. Minogue, Alexander S. Hebert et al. · 2017 · eLife
  96. Global Analysis of Enhancer Targets Reveals Convergent Enhancer-Driven Regulatory Modules
    Shiqi Xie, Daniel A. Armendariz, Pei Zhou, Jialei Duan, Gary C. Hon · 2019 · Cell Reports
  97. g(HbF): a genetic model of fetal hemoglobin in sickle cell disease
    Gardner, Kate, Fulford, Tony, Silver, Nicholas, Rooks, Helen, Angelis, Nikolaos, Allman, Marlene, Nkya, Siana, Makani, Julie, Howard, Jo, Kesse-Adu, Rachel et al. · 2018 · Blood Advances
  98. Hemoglobin genetics: recent contributions of GWAS and gene editing
    Elenoe C. Smith, Stuart H. Orkin · 2016 · Human Molecular Genetics
  99. A Genetic Variant Ameliorates β-Thalassemia Severity by Epigenetic-Mediated Elevation of Human Fetal Hemoglobin Expression
    Diyu Chen, Yangjin Zuo, Xinhua Zhang, Yuhua Ye, Xiuqin Bao, Haiyan Huang, Wanicha Tepakhan, Lijuan Wang, Junyi Ju, Guangfu Chen et al. · 2017 · The American Journal of Human Genetics
  100. Enhancer dysfunction in leukemia
    Anand S. Bhagwat, Bin Lu, Christopher R. Vakoc · 2018 · Blood